MedCity News October 11, 2024
For 2025, the average star rating for Medicare Advantage Prescription Drug contracts was 3.92, compared to 4.07 for 2024, 4.14 for 2023 and 4.37 for 2022.
Average Medicare Advantage star ratings have declined once again, the Centers for Medicare and Medicaid Services (CMS) announced Thursday.
For 2025, the average star rating for Medicare Advantage Prescription Drug contracts was 3.92, compared to 4.07 for 2024, 4.14 for 2023 and 4.37 for 2022. Only seven contracts received a five-star rating for 2025, compared to 38 in 2024.
About 40% of Medicare Advantage Prescription Drug contracts that will be offered in 2025 received at least four stars. In addition, about 62% of Medicare Advantage Prescription Drug enrollees are currently in contracts with...
Today's Sponsors
Today's Sponsor